Summit Therapeutics (NasdaqGM:SMMT) Update / Briefing Transcript

Summit Therapeutics (NasdaqGM:SMMT) Update / Briefing September 08, 2025 08:00 AM ET Company ParticipantsDave Gancarz - Chief Business & Strategy OfficerH. Jack West - VP - Clinical DevelopmentYigal Nochomovitz - DirectorSalveen Richter - Biotechnology Equity ResearchGreg Wiessner - Biotech Equity Research AssociateCory Kasimov - Senior Managing DirectorManmeet Soni - COO & CFOMohit Bansal - MD & Co-Head - Therapeutics ResearchNone - ExecutiveDaina Graybosch - Senior MD - Immuno-OncologyClara Dong - VP - Eq ...